| #51 |
Jessica A. Sorrentino |
G1 Therapeutics |
3 |
| #51 |
Farshid Guilak |
Cytex Therapeutics |
3 |
| #51 |
Kelly Camus |
IBM |
3 |
| #51 |
Qiudeng Que |
Syngenta Participations Ag |
3 |
| #51 |
Adam T. C. Steege |
Bayer Healthcare |
3 |
| #51 |
Colin Cooke |
Ramona Optics |
3 |
| #51 |
Larry Glenn Estes |
Lenovo (Singapore) Pte. |
3 |
| #51 |
Etienne Menard |
University Of Illinois |
3 |
| #51 |
Michael J. Therien |
Duke University |
3 |
| #51 |
Yuan Lin |
Carestream Health |
3 |
| #51 |
Zachary C. Hartman |
Duke University |
3 |
| #51 |
Rupa Shetty |
Prelude Therapeutics, Incorporated |
3 |
| #51 |
David Suich |
Creeled |
3 |
| #51 |
George FROMM |
Shattuck Labs |
3 |
| #51 |
Chun Yu Liu |
Himax Technologies Limited |
3 |
| #51 |
Samir A. Nasser |
IBM |
3 |
| #51 |
Ngoc A. Nguyen |
Ut-Battelle |
3 |
| #51 |
Haixin Yang |
E.I. Du Pont De Nemours And |
3 |
| #51 |
Howard David Glicksman |
E.I. Du Pont De Nemours And |
3 |
| #51 |
Daniel T. MacLeod |
Precision Biosciences |
3 |
| #51 |
John W. Wilson |
Axon Enterprise |
3 |
| #51 |
Kevin N. Magill |
IBM |
3 |
| #51 |
John Scott Crowe |
Lenovo (Singapore) Pte. |
3 |
| #51 |
Jin Leem |
IBM |
3 |
| #51 |
Yuqian Li |
Nanjing University |
3 |
| #51 |
Herbert K. Lyerly |
Duke University |
3 |
| #51 |
Yan Zhang |
Duke University |
3 |
| #51 |
Eli B. Nichols |
Becton, Dickinson And |
3 |
| #51 |
Takuya Osada |
Duke University |
3 |
| #51 |
Victor Bartsevich |
Precision Biosciences |
3 |
| #51 |
Justus Adamson |
Duke University |
3 |
| #51 |
Barton F. Haynes |
Duke University |
3 |
| #51 |
Philip Lee Childs |
Lenovo (Singapore) Pte. |
3 |
| #51 |
Tomas Sadilek |
GE |
3 |
| #51 |
Sudhir Shrikantha Kudva |
NVIDIA |
3 |
| #51 |
Thomas Claiborne Lovelace |
Fennec Pharmaceuticals |
3 |
| #51 |
Michael Hoffman |
Rovi Guides |
3 |
| #51 |
Ian W. Davis |
Monsanto Technology |
3 |
| #51 |
David T. Emerson |
Cree |
3 |
| #51 |
Selene G. Parekh |
Paragon Advanced Technologies |
3 |
| #51 |
Xijia Lu |
8 Rivers Capital |
3 |
| #51 |
Ryan T. Hill |
Biofire Defense |
3 |
| #93 |
Mark W. Dewhirst |
Duke University |
2 |
| #93 |
Nathan J. Cobb |
Mesa Biotech |
2 |
| #93 |
Joseph A. DaCorta |
Entegrion |
2 |
| #93 |
Navid Rafati |
8 Rivers Capital |
2 |
| #93 |
Robert G. Strickley |
Gilead Sciences |
2 |
| #93 |
James W. Mitchell |
— |
2 |
| #93 |
Brian S. Turk |
Research Triangle Institute |
2 |
| #93 |
Jesse Daniel Sookne |
Sas Institute |
2 |